635 related articles for article (PubMed ID: 27282474)
1. ALS and FTD: an epigenetic perspective.
Belzil VV; Katzman RB; Petrucelli L
Acta Neuropathol; 2016 Oct; 132(4):487-502. PubMed ID: 27282474
[TBL] [Abstract][Full Text] [Related]
2. An Epigenetic Spin to ALS and FTD.
Ebbert MTW; Lank RJ; Belzil VV
Adv Neurobiol; 2018; 20():1-29. PubMed ID: 29916014
[TBL] [Abstract][Full Text] [Related]
3. Tale of two diseases: amyotrophic lateral sclerosis and frontotemporal dementia.
Verma A
Neurol India; 2014; 62(4):347-51. PubMed ID: 25237937
[TBL] [Abstract][Full Text] [Related]
4. There has been an awakening: Emerging mechanisms of C9orf72 mutations in FTD/ALS.
Gitler AD; Tsuiji H
Brain Res; 2016 Sep; 1647():19-29. PubMed ID: 27059391
[TBL] [Abstract][Full Text] [Related]
5. TBK1 mutation frequencies in French frontotemporal dementia and amyotrophic lateral sclerosis cohorts.
Le Ber I; De Septenville A; Millecamps S; Camuzat A; Caroppo P; Couratier P; Blanc F; Lacomblez L; Sellal F; Fleury MC; Meininger V; Cazeneuve C; Clot F; Flabeau O; LeGuern E; Brice A;
Neurobiol Aging; 2015 Nov; 36(11):3116.e5-3116.e8. PubMed ID: 26476236
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic Mechanisms of Gene Regulation in Amyotrophic Lateral Sclerosis.
Jimenez-Pacheco A; Franco JM; Lopez S; Gomez-Zumaquero JM; Magdalena Leal-Lasarte M; Caballero-Hernandez DE; Cejudo-Guillén M; Pozo D
Adv Exp Med Biol; 2017; 978():255-275. PubMed ID: 28523551
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis of ALS and FTD: implications for translational studies.
Liščić RM
Arh Hig Rada Toksikol; 2015 Dec; 66(4):285-90. PubMed ID: 26751860
[TBL] [Abstract][Full Text] [Related]
8. Pathogenic determinants and mechanisms of ALS/FTD linked to hexanucleotide repeat expansions in the C9orf72 gene.
Wen X; Westergard T; Pasinelli P; Trotti D
Neurosci Lett; 2017 Jan; 636():16-26. PubMed ID: 27619540
[TBL] [Abstract][Full Text] [Related]
9. Selective Genetic Overlap Between Amyotrophic Lateral Sclerosis and Diseases of the Frontotemporal Dementia Spectrum.
Karch CM; Wen N; Fan CC; Yokoyama JS; Kouri N; Ross OA; Höglinger G; Müller U; Ferrari R; Hardy J; Schellenberg GD; Sleiman PM; Momeni P; Hess CP; Miller BL; Sharma M; Van Deerlin V; Smeland OB; Andreassen OA; Dale AM; Desikan RS;
JAMA Neurol; 2018 Jul; 75(7):860-875. PubMed ID: 29630712
[TBL] [Abstract][Full Text] [Related]
10. Genetics insight into the amyotrophic lateral sclerosis/frontotemporal dementia spectrum.
Ji AL; Zhang X; Chen WW; Huang WJ
J Med Genet; 2017 Mar; 54(3):145-154. PubMed ID: 28087719
[TBL] [Abstract][Full Text] [Related]
11. Common Molecular Pathways in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
Weishaupt JH; Hyman T; Dikic I
Trends Mol Med; 2016 Sep; 22(9):769-783. PubMed ID: 27498188
[TBL] [Abstract][Full Text] [Related]
12. Structural insight into C9orf72 hexanucleotide repeat expansions: Towards new therapeutic targets in FTD-ALS.
Kumar V; Kashav T; Islam A; Ahmad F; Hassan MI
Neurochem Int; 2016 Nov; 100():11-20. PubMed ID: 27539655
[TBL] [Abstract][Full Text] [Related]
13. FTD and ALS: genetic ties that bind.
Orr HT
Neuron; 2011 Oct; 72(2):189-90. PubMed ID: 22017980
[TBL] [Abstract][Full Text] [Related]
14. Insights into the pathogenic mechanisms of Chromosome 9 open reading frame 72 (C9orf72) repeat expansions.
Todd TW; Petrucelli L
J Neurochem; 2016 Aug; 138 Suppl 1():145-62. PubMed ID: 27016280
[TBL] [Abstract][Full Text] [Related]
15. Association between TBK1 mutations and risk of amyotrophic lateral sclerosis/frontotemporal dementia spectrum: a meta-analysis.
Cui R; Tuo M; Li P; Zhou C
Neurol Sci; 2018 May; 39(5):811-820. PubMed ID: 29349657
[TBL] [Abstract][Full Text] [Related]
16. [Overlapping features of frontotemporal dementia and amyotrophic lateral sclerosis].
Lillo P; Matamala JM; Valenzuela D; Verdugo R; Castillo JL; Ibáñez A; Slachevsky A
Rev Med Chil; 2014 Jul; 142(7):867-79. PubMed ID: 25378006
[TBL] [Abstract][Full Text] [Related]
17. Screening in ALS and FTD patients reveals 3 novel UBQLN2 mutations outside the PXX domain and a pure FTD phenotype.
Synofzik M; Maetzler W; Grehl T; Prudlo J; Vom Hagen JM; Haack T; Rebassoo P; Munz M; Schöls L; Biskup S
Neurobiol Aging; 2012 Dec; 33(12):2949.e13-7. PubMed ID: 22892309
[TBL] [Abstract][Full Text] [Related]
18. Development of Therapeutics for C9ORF72 ALS/FTD-Related Disorders.
Mis MSC; Brajkovic S; Tafuri F; Bresolin N; Comi GP; Corti S
Mol Neurobiol; 2017 Aug; 54(6):4466-4476. PubMed ID: 27349438
[TBL] [Abstract][Full Text] [Related]
19. Analysis of C9orf72 in patients with frontotemporal dementia and amyotrophic lateral sclerosis from Argentina.
Itzcovich T; Xi Z; Martinetto H; Chrem-Méndez P; Russo MJ; de Ambrosi B; Uchitel OD; Nogués M; Silva E; Rojas G; Bagnatti P; Amengual A; Campos J; Rogaeva E; St George-Hyslop P; Allegri R; Sevlever G; Surace EI
Neurobiol Aging; 2016 Apr; 40():192.e13-192.e15. PubMed ID: 26925510
[TBL] [Abstract][Full Text] [Related]
20. Trichostatin A Relieves Growth Suppression and Restores Histone Acetylation at Specific Sites in a FUS ALS/FTD Yeast Model.
Bennett SA; Cobos SN; Mirzakandova M; Fallah M; Son E; Angelakakis G; Rana N; Hugais M; Torrente MP
Biochemistry; 2021 Dec; 60(48):3671-3675. PubMed ID: 34788013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
